AstraZeneca Papers Raise Seroquel Issues

February 27, 2009

AstraZeneca PLC instructed its U.S. sales representatives to tell doctors that its powerful psychiatric drug, Seroquel, didn’t cause diabetes even though a company physician had at one point stated years earlier that such a link was probable in some individuals, documents unsealed in a federal court case here show. [Premium (Wall Street Journal)]